Summary
Definition
History and exam
Key diagnostic factors
- presence of risk factors
- fevers and night sweats
- weight loss
- skin rashes and post-inflammatory scars
- oral ulcers, angular cheilitis, oral thrush, or oral hairy leukoplakia
- diarrhoea
- wasting syndrome
- changes in mental status or neuropsychiatric function
- recent hospital admissions
- tuberculosis (TB)
- medical comorbidities
- sexual activity
- generalised lymphadenopathy
- Kaposi's sarcoma
- genital STIs
- chronic vaginal candidiasis
- shingles
- headaches
- periodontal disease
- retinal lesions on fundoscopy
- shortness of breath on exertion, cyanosis on exertion, dry cough, silent chest on auscultation
Other diagnostic factors
- current and prior use of other substances
- peripheral neuropathy
- recurrent herpes simplex
- hepatomegaly or splenomegaly
- meningeal signs (bacterial or viral meningitis)
Risk factors
- people who inject drugs
- gay men and other men who have sex with men
- commercial sex worker
- transgender women
- unprotected receptive anal intercourse
- unprotected receptive penile-vaginal sexual intercourse
- percutaneous needle stick injury
- racial and ethnic minorities
- high maternal viral load (mother to child transmission)
- use of progestin-only injectable contraceptives
- herpes simplex virus type 2 (HSV-2) infection
Diagnostic investigations
1st investigations to order
- serum HIV enzyme-linked immunosorbent assay (ELISA)
- serum HIV rapid test
- HIV non-invasive tests
- serum Western blot
- serum p24 antigen
- serum HIV DNA polymerase chain reaction (PCR)
- CD4 count
- serum viral load (HIV RNA)
- drug resistance testing
- pregnancy test
- serum hepatitis B serology
- serum hepatitis C serology
- FBC with differential
- basic metabolic panel
- urinalysis
- liver function tests (LFTs)
- random or fasting plasma glucose
- lipid profile
- human leukocyte antigen-B*5701 testing
Investigations to consider
- chest x-ray
- hepatitis A serology (IgG)
- toxoplasma serology (IgG)
- testing for sexually transmitted infections
- tuberculin skin test
Treatment algorithm
newly confirmed infection
virological or immunological treatment failure
Contributors
Authors
Chad J. Achenbach, MD, MPH
Associate Professor of Medicine
Infectious Diseases
Northwestern Medicine
Feinberg School of Medicine, Northwestern University
Chicago
IL
Disclosures
CJA declares that he has no competing interests.
Acknowledgements
Dr Chad J. Achenbach would like to gratefully acknowledge Dr Richard Rothman, Dr Michael Ehmann, Dr Linda-Gail Bekker, Dr Catherine Orrell, and Dr Lisa Capaldini, the previous contributors to this topic.
Disclosures
ME, LGB, and CO declare that they have no competing interests. RR attended a symposium/conference hosted by a funding agency, Gilead HIV FOCUS programme, from which he receives research funds. RR pays staff for an implementation/research programme grant from Gilead HIV FOCUS for development of HIV testing programmes in Emergency Departments. LC is on the speakers' bureau for the following pharmaceutical companies: GlaxoSmithKline, BMS, Merck, Gilead, Roche, Pfizer, Solvay, Lilly, Serrano, and Tibotec.
Peer reviewers
Marianne Harris, MD
Clinical Assistant Professor
University of British Columbia
Vancouver
Canada
Disclosures
MH is a member of an advisory board and/or speakers' bureau for Gilead Sciences Canada Inc, Merck Canada Inc, and ViiV Healthcare.
William Rodriguez, MD
Assistant Professor of Medicine
Harvard Medical School
Director of Research
Global Health Delivery Project
Harvard School of Public Health
Boston
MA
Disclosures
WR declares that he has no competing interests.
Jeremy Day, BChir, MB
Infectious Disease Physician
Oxford University Clinical Research Unit
Hospital for Tropical Diseases
Ho Chi Minh City
Vietnam
Disclosures
JD declares that he has no competing interests.
Differentials
- Infectious mononucleosis
- Cytomegalovirus infection (CMV)
- Influenza infection
More DifferentialsGuidelines
- Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV
- Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV
More GuidelinesPatient information
HIV: what is it?
HIV: testing
More Patient informationVideos
Venepuncture and phlebotomy animated demonstration
More videosLog in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer